SuperworthDyne Therapeutics shares outstanding DYN
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 165.5M
- On a year earlier
- +45.3%
- more shares
Dyne Therapeutics had 165.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 45.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 147.6M | +45% |
| FY2024 | 102M | +66% |
| FY2023 | 61.4M | +16% |
| FY2022 | 52.8M | +2% |
| FY2021 | 51.5M | +1908% |
| FY2019 | 2.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 165.5M | +45% | |
| Q1 FY26 | 165M | +50% | |
| Q4 FY25 | 147.6M | +45% | |
| Q3 FY25 | 141.8M | +41% | |
| Q2 FY25 | 113.9M | +23% | |
| Q1 FY25 | 109.9M | +36% | |
| Q4 FY24 | 102M | +66% | |
| Q3 FY24 | 100.9M | +65% | |
| Q2 FY24 | 92.5M | +55% | |
| Q1 FY24 | 81M | +44% | |
| Q4 FY23 | 61.4M | +16% | |
| Q3 FY23 | 61.1M | +18% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Dyne Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.